Innospec (IOSP) Competitors

$80.82 +0.27 (+0.34%)

Closing price 05/11/2026 04:00 PM Eastern

Extended Trading

$81.00 +0.18 (+0.22%)

As of 05/11/2026 06:25 PM Eastern

IOSP vs. FFBC, IBOC, UBSI, AVNT, and CBT

Should you be buying Innospec stock or one of its competitors? The main competitors of Innospec include First Financial Bancorp. (FFBC), International Bancshares (IBOC), United Bankshares (UBSI), Avient (AVNT), and Cabot (CBT).

How does Innospec compare to First Financial Bancorp.?

Innospec (NASDAQ:IOSP) and First Financial Bancorp. (NASDAQ:FFBC) are related mid-cap companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk.

In the previous week, Innospec had 14 more articles in the media than First Financial Bancorp.. MarketBeat recorded 18 mentions for Innospec and 4 mentions for First Financial Bancorp.. First Financial Bancorp.'s average media sentiment score of 1.15 beat Innospec's score of 0.85 indicating that First Financial Bancorp. is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Innospec	4 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
First Financial Bancorp.	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

96.6% of Innospec shares are owned by institutional investors. Comparatively, 77.2% of First Financial Bancorp. shares are owned by institutional investors. 1.5% of Innospec shares are owned by insiders. Comparatively, 1.1% of First Financial Bancorp. shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

First Financial Bancorp. has a net margin of 20.92% compared to Innospec's net margin of 6.38%. First Financial Bancorp.'s return on equity of 11.09% beat Innospec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innospec	6.38%	9.32%	6.79%
First Financial Bancorp.	20.92%	11.09%	1.49%

Innospec pays an annual dividend of $1.74 per share and has a dividend yield of 2.2%. First Financial Bancorp. pays an annual dividend of $1.00 per share and has a dividend yield of 3.3%. Innospec pays out 37.9% of its earnings in the form of a dividend. First Financial Bancorp. pays out 35.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Innospec has increased its dividend for 11 consecutive years and First Financial Bancorp. has increased its dividend for 1 consecutive years. First Financial Bancorp. is clearly the better dividend stock, given its higher yield and lower payout ratio.

First Financial Bancorp. has lower revenue, but higher earnings than Innospec. First Financial Bancorp. is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innospec	$1.78B	1.13	$116.60M	$4.59	17.61
First Financial Bancorp.	$1.26B	2.51	$255.60M	$2.83	10.64

First Financial Bancorp. has a consensus target price of $33.00, indicating a potential upside of 9.60%. Given First Financial Bancorp.'s stronger consensus rating and higher possible upside, analysts plainly believe First Financial Bancorp. is more favorable than Innospec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innospec	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
First Financial Bancorp.	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Innospec has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market. Comparatively, First Financial Bancorp. has a beta of 0.94, meaning that its share price is 6% less volatile than the broader market.

Summary

First Financial Bancorp. beats Innospec on 11 of the 19 factors compared between the two stocks.

How does Innospec compare to International Bancshares?

Innospec (NASDAQ:IOSP) and International Bancshares (NASDAQ:IBOC) are related mid-cap companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation, institutional ownership and media sentiment.

Innospec has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market. Comparatively, International Bancshares has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market.

International Bancshares has lower revenue, but higher earnings than Innospec. International Bancshares is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innospec	$1.78B	1.13	$116.60M	$4.59	17.61
International Bancshares	$1.06B	4.30	$412.29M	$6.70	10.89

In the previous week, Innospec had 13 more articles in the media than International Bancshares. MarketBeat recorded 18 mentions for Innospec and 5 mentions for International Bancshares. Innospec's average media sentiment score of 0.85 beat International Bancshares' score of 0.18 indicating that Innospec is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Innospec	4 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
International Bancshares	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

International Bancshares has a consensus price target of $85.00, indicating a potential upside of 16.50%. Given International Bancshares' stronger consensus rating and higher probable upside, analysts clearly believe International Bancshares is more favorable than Innospec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innospec	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
International Bancshares	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Innospec pays an annual dividend of $1.74 per share and has a dividend yield of 2.2%. International Bancshares pays an annual dividend of $1.46 per share and has a dividend yield of 2.0%. Innospec pays out 37.9% of its earnings in the form of a dividend. International Bancshares pays out 21.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Innospec has raised its dividend for 11 consecutive years and International Bancshares has raised its dividend for 16 consecutive years.

96.6% of Innospec shares are held by institutional investors. Comparatively, 65.9% of International Bancshares shares are held by institutional investors. 1.5% of Innospec shares are held by insiders. Comparatively, 13.4% of International Bancshares shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

International Bancshares has a net margin of 39.33% compared to Innospec's net margin of 6.38%. International Bancshares' return on equity of 13.16% beat Innospec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innospec	6.38%	9.32%	6.79%
International Bancshares	39.33%	13.16%	2.52%

Summary

International Bancshares beats Innospec on 11 of the 19 factors compared between the two stocks.

How does Innospec compare to United Bankshares?

United Bankshares (NASDAQ:UBSI) and Innospec (NASDAQ:IOSP) are related mid-cap companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability.

United Bankshares has a beta of 0.72, indicating that its share price is 28% less volatile than the broader market. Comparatively, Innospec has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market.

In the previous week, Innospec had 15 more articles in the media than United Bankshares. MarketBeat recorded 18 mentions for Innospec and 3 mentions for United Bankshares. United Bankshares' average media sentiment score of 1.26 beat Innospec's score of 0.85 indicating that United Bankshares is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
United Bankshares	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Innospec	4 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

United Bankshares currently has a consensus price target of $45.75, suggesting a potential upside of 7.44%. Given United Bankshares' stronger consensus rating and higher possible upside, research analysts clearly believe United Bankshares is more favorable than Innospec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
United Bankshares	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Innospec	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

United Bankshares has a net margin of 27.45% compared to Innospec's net margin of 6.38%. Innospec's return on equity of 9.32% beat United Bankshares' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
United Bankshares	27.45%	9.26%	1.51%
Innospec	6.38%	9.32%	6.79%

United Bankshares has higher revenue and earnings than Innospec. United Bankshares is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
United Bankshares	$1.82B	3.27	$464.60M	$3.57	11.93
Innospec	$1.78B	1.13	$116.60M	$4.59	17.61

70.8% of United Bankshares shares are held by institutional investors. Comparatively, 96.6% of Innospec shares are held by institutional investors. 3.2% of United Bankshares shares are held by company insiders. Comparatively, 1.5% of Innospec shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

United Bankshares pays an annual dividend of $1.52 per share and has a dividend yield of 3.6%. Innospec pays an annual dividend of $1.74 per share and has a dividend yield of 2.2%. United Bankshares pays out 42.6% of its earnings in the form of a dividend. Innospec pays out 37.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. United Bankshares has increased its dividend for 26 consecutive years and Innospec has increased its dividend for 11 consecutive years. United Bankshares is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

United Bankshares beats Innospec on 11 of the 19 factors compared between the two stocks.

How does Innospec compare to Avient?

Avient (NYSE:AVNT) and Innospec (NASDAQ:IOSP) are both mid-cap basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

Avient has a beta of 1.31, suggesting that its share price is 31% more volatile than the broader market. Comparatively, Innospec has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market.

95.5% of Avient shares are held by institutional investors. Comparatively, 96.6% of Innospec shares are held by institutional investors. 0.9% of Avient shares are held by insiders. Comparatively, 1.5% of Innospec shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Avient had 2 more articles in the media than Innospec. MarketBeat recorded 20 mentions for Avient and 18 mentions for Innospec. Innospec's average media sentiment score of 0.85 beat Avient's score of 0.59 indicating that Innospec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avient	5 Very Positive mention(s)	2 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Innospec	4 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Avient pays an annual dividend of $1.10 per share and has a dividend yield of 3.1%. Innospec pays an annual dividend of $1.74 per share and has a dividend yield of 2.2%. Avient pays out 64.0% of its earnings in the form of a dividend. Innospec pays out 37.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Avient has increased its dividend for 1 consecutive years and Innospec has increased its dividend for 11 consecutive years.

Innospec has a net margin of 6.38% compared to Avient's net margin of 4.81%. Avient's return on equity of 11.11% beat Innospec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avient	4.81%	11.11%	4.40%
Innospec	6.38%	9.32%	6.79%

Avient currently has a consensus price target of $46.40, suggesting a potential upside of 28.91%. Given Avient's stronger consensus rating and higher possible upside, equities analysts plainly believe Avient is more favorable than Innospec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avient	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Innospec	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Innospec has lower revenue, but higher earnings than Avient. Innospec is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avient	$3.28B	1.01	$81.90M	$1.72	20.93
Innospec	$1.78B	1.13	$116.60M	$4.59	17.61

Summary

Innospec beats Avient on 10 of the 19 factors compared between the two stocks.

How does Innospec compare to Cabot?

Cabot (NYSE:CBT) and Innospec (NASDAQ:IOSP) are both mid-cap basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

Cabot pays an annual dividend of $1.80 per share and has a dividend yield of 2.1%. Innospec pays an annual dividend of $1.74 per share and has a dividend yield of 2.2%. Cabot pays out 34.0% of its earnings in the form of a dividend. Innospec pays out 37.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has increased its dividend for 14 consecutive years and Innospec has increased its dividend for 11 consecutive years.

In the previous week, Cabot had 7 more articles in the media than Innospec. MarketBeat recorded 25 mentions for Cabot and 18 mentions for Innospec. Cabot's average media sentiment score of 0.85 beat Innospec's score of 0.85 indicating that Cabot is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cabot	11 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Innospec	4 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Cabot has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market. Comparatively, Innospec has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market.

Cabot has higher revenue and earnings than Innospec. Cabot is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cabot	$3.71B	1.17	$331M	$5.29	15.97
Innospec	$1.78B	1.13	$116.60M	$4.59	17.61

93.2% of Cabot shares are held by institutional investors. Comparatively, 96.6% of Innospec shares are held by institutional investors. 3.1% of Cabot shares are held by insiders. Comparatively, 1.5% of Innospec shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Cabot has a net margin of 7.97% compared to Innospec's net margin of 6.38%. Cabot's return on equity of 21.33% beat Innospec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cabot	7.97%	21.33%	9.48%
Innospec	6.38%	9.32%	6.79%

Cabot currently has a consensus price target of $76.25, suggesting a potential downside of 9.76%. Given Cabot's higher possible upside, equities analysts plainly believe Cabot is more favorable than Innospec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cabot	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Innospec	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Cabot beats Innospec on 14 of the 18 factors compared between the two stocks.

Get Innospec News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IOSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IOSP vs. The Competition

Export

Metric	Innospec	CHEM Industry	Materials Sector	NASDAQ Exchange
Market Cap	$2.00B	$13.82B	$4.92B	$12.31B
Dividend Yield	2.16%	2.23%	4.96%	5.23%
P/E Ratio	17.61	38.44	23.48	25.69
Price / Sales	1.13	2.04	7,485.54	76.29
Price / Cash	11.37	12.31	24.46	36.29
Price / Book	1.50	2.05	7.08	6.74
Net Income	$116.60M	$179.02M	$159.16M	$333.18M
7 Day Performance	3.41%	1.15%	4.35%	0.42%
1 Month Performance	6.82%	5.51%	4.60%	8.99%
1 Year Performance	-10.89%	38.65%	84.79%	37.93%

Innospec Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IOSP Innospec	3.7978 of 5 stars	$80.82 +0.3%	N/A	-10.7%	$2.00B	$1.78B	17.61	2,450	Earnings Report Analyst Downgrade
FFBC First Financial Bancorp.	4.0858 of 5 stars	$29.99 -1.4%	$33.00 +10.1%	+25.1%	$3.19B	$961.73M	10.60	2,199
IBOC International Bancshares	3.0636 of 5 stars	$71.12 -0.8%	$85.00 +19.5%	+15.5%	$4.46B	$1.06B	10.74	2,319	Earnings Report
UBSI United Bankshares	3.9027 of 5 stars	$43.07 -1.4%	$45.75 +6.2%	+19.9%	$6.10B	$1.26B	12.06	2,694	Positive News
AVNT Avient	4.6261 of 5 stars	$35.56 -3.3%	$47.00 +32.2%	-2.2%	$3.37B	$3.26B	39.96	9,000	Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IOSP) was last updated on 5/12/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Innospec (IOSP) Competitors

IOSP vs. FFBC, IBOC, UBSI, AVNT, and CBT

How does Innospec compare to First Financial Bancorp.?

Summary

How does Innospec compare to International Bancshares?

Summary

How does Innospec compare to United Bankshares?

Summary

How does Innospec compare to Avient?

Summary

How does Innospec compare to Cabot?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IOSP vs. The Competition

Innospec Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Innospec (IOSP) Competitors

IOSP vs. FFBC, IBOC, UBSI, AVNT, and CBT

How does Innospec compare to First Financial Bancorp.?

Does the media refer more to IOSP or FFBC?

Do institutionals and insiders hold more shares of IOSP or FFBC?

Is IOSP or FFBC more profitable?

Is IOSP or FFBC a better dividend stock?

Which has higher earnings and valuation, IOSP or FFBC?

Do analysts rate IOSP or FFBC?

Which has more risk and volatility, IOSP or FFBC?

Summary

How does Innospec compare to International Bancshares?

Which has more risk & volatility, IOSP or IBOC?

Which has stronger earnings & valuation, IOSP or IBOC?

Does the media refer more to IOSP or IBOC?

Do analysts prefer IOSP or IBOC?

Is IOSP or IBOC a better dividend stock?

Do insiders and institutionals hold more shares of IOSP or IBOC?

Is IOSP or IBOC more profitable?

Summary

How does Innospec compare to United Bankshares?

Which has more risk and volatility, UBSI or IOSP?

Does the media refer more to UBSI or IOSP?

Do analysts recommend UBSI or IOSP?

Is UBSI or IOSP more profitable?

Which has stronger valuation & earnings, UBSI or IOSP?

Do insiders & institutionals have more ownership in UBSI or IOSP?

Is UBSI or IOSP a better dividend stock?

Summary

How does Innospec compare to Avient?

Which has more risk & volatility, AVNT or IOSP?

Do insiders and institutionals hold more shares of AVNT or IOSP?

Does the media prefer AVNT or IOSP?

Is AVNT or IOSP a better dividend stock?

Is AVNT or IOSP more profitable?

Do analysts recommend AVNT or IOSP?

Which has higher valuation and earnings, AVNT or IOSP?

Summary

How does Innospec compare to Cabot?

Is CBT or IOSP a better dividend stock?

Does the media prefer CBT or IOSP?

Which has more risk & volatility, CBT or IOSP?

Which has higher valuation and earnings, CBT or IOSP?

Do insiders and institutionals hold more shares of CBT or IOSP?

Is CBT or IOSP more profitable?

Do analysts recommend CBT or IOSP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IOSP vs. The Competition

Innospec Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools